WELCOME TO The Biotechnology REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Boosting R&D Productivity With Pooled CRISPR Screening
June 23, 2019
I'm For Real
Enter your details once to access all our information and resources
We are a biotech company based in San Francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as Alzheimer's Disease.
whitePaper | November 28, 2022
The Asia-Pacific area is home to around two thirds of the world’s population and has a wide range of cultural, political, economic, and other factors that affect vaccine development, use, and registration.
whitePaper | February 3, 2023
Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.
whitePaper | February 25, 2022
Digitalization and automation promise a better way to streamline the transfer of cell and gene therapies from drug discovery – to commercial production.
whitePaper | May 30, 2022
Many concerns are being expressed about the biodegradability, biocompatibility, and longterm viability of polymer-based substances. This prompted the quest for an alternative source of material that could be utilized for various purposes.
whitePaper | September 12, 2022
Lipid nanoparticles (LNPs) and liposomes are variations of lipid-based drug carriers differing in their internal structure.
whitePaper | November 4, 2019
Revenues from biologics increased by 70% from 2011 to 2016. Biologics account for 20-22% of total pharmaceutical spending. IQVIA estimates US biologics spending will reach $320bn by 2023
Conference
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE